Interleukin 28B rs12979860 CT, rs12980275 GA, rs8099917 GT and TT genotypes are the Predictors of Rapid Viral Response in Hepatitis C Virus-Infected Patients
Journal Title: Viral Hepatitis Journal - Year 2016, Vol 22, Issue 3
Abstract
Objective: In this study, the effects of genotypic differences on the clinical course of the disease, response to treatment and fibrosis were investigated in patients with hepatitis C virus (HCV) infection. Materials and Methods: Ninety-nine chronic HCV-infected patients and 95 controls were enrolled. The patients received pegylated interferon (PegIFN) + ribavirin (RBV) for 48 weeks and followed up for the next 48 weeks. Aspartate aminotransferase/platelet ratio index was used to determine the stage of liver fibrosis. DNA specimens were extracted from peripheral blood mononuclear cells and the interleukin (IL) 28B gene rs12979860, rs12980275, and rs8099917 were genotyped by the immune polymerase chain reaction-restriction fragment length polymorphism method. Results were analysed using the SPSS 16.0 and OpenEpi 2.2 softwares. Results: All patients had HCV genotype 1. Among the 99 HCV+ patients, in 26.3% spontaneous viral clearance, in 42.8% rapid viral response, 92% early viral response and in 72.6% sustained viral response was observed. The allele frequencies of IL28B single nucleotide polymorphisms (SNP), rs12979860, rs12980275, and rs8099917 were not identical in all samples (p<0.005). SNP rs12979860 CT genotype (p=0.010); rs12980275 GA genotype (p=0.010); and rs8099917 GT and TT genotypes (p=0.019 and 0.020, respectively) were strongly associated with rapid viral response in the overall sample. Conclusion: The determination of IL28B polymorphisms may be useful to individualize treatment options when using PEG/RBV-based therapies for chronic HCV infection but genetic characteristics of populations of the countries must be known.
Authors and Affiliations
Aydın RÜSTEMOĞLU, Didem YALÇIN, Özgür GÜNAL, Betül ÇELİK, Şener BARUT, Ömer ATEŞ
Keywords
Related Articles
- EP ID EP228499
- DOI 10.4274/vhd.51523
- Views 65
- Downloads 0
Relationship Between Basic Laboratory Results and Fibrosis in Chronic Hepatitis B Patients
Objectives: Liver biopsy (LB) is an important cornerstone in decision to start treatment for chronic hepatitis B (HB). Viral load and liver function tests are performed to determine the most appropriate time. In this stu...
Immunosuppressive Therapy and Hepatitis B Virus Reactivation
Reactivation of hepatitis B virus (HBV) refers to reappearance of active necroinflammatory disease of the liver in an individual at an inactive hepatitis B surface antigen carrier state or who is known to have resolved H...
Percutaneous Liver Needle Biopsy Methods Can Be Safe and Effective in Patients with Viral Hepatitis
Objectives: The aims of this study were to evaluate the biopsy methods used in terms of safety, and effectiveness as well as incidence, and severity of complications. Materials and Methods: This study was conducted as a...
Non-hodgkin Lymphoma Developing After Discontinuation of Direct-acting Antiviral Treatment for Hepatitis C: A Case Report
Today, direct-acting antivirals (DAA) are the main treatment options for hepatitis C infection. However, whether malignancy risk is increased after DAA treatment is a matter of debate. Conflicting results have been repor...
How to Diagnosis the Occult Hepatitis C Virus?
Editorial